← Back to Search

Artificial Intelligence

Point of Care Autonomous AI diabetic retinopathy exam for Type 1 Diabetes (ACCESS Trial)

N/A
Waitlist Available
Led By Risa Wolf, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

ACCESS Trial Summary

This trial will test if giving patients in-clinic exams for diabetic retinopathy using AI improves screening rates compared to referring them to an eye care provider.

Eligible Conditions
  • Type 1 Diabetes
  • Type 2 Diabetes

ACCESS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Who Get Screened With a Diabetic Eye Exam
Secondary outcome measures
Follow-up Rates With an Eye Care Provider

ACCESS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Diabetic Retinopathy ExamExperimental Treatment1 Intervention
Point of care (POC) Diabetic Retinopathy Exam using Autonomous AI on non-mydriatic fundus camera
Group II: Usual care with educational reinforcementActive Control1 Intervention
Standard of care referral to Eye Care Provider (ECP) for the diabetic eye exam with educational reinforcement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Point of Care Autonomous AI diabetic retinopathy exam
2021
N/A
~170

Find a Location

Who is running the clinical trial?

National Eye Institute (NEI)NIH
546 Previous Clinical Trials
1,401,764 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,262 Previous Clinical Trials
14,823,000 Total Patients Enrolled
Risa Wolf, MDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
26 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings remaining in this investigation?

"This study is no longer actively enrolling patients, as reported on clinicaltrials.gov, despite being initially posted back in November 2021 and updated nearly a year later. Nevertheless, 1410 other trials are available to join at this time."

Answered by AI

What criteria must individuals meet to qualify for participation in this research?

"164 participants with type 2 diabetes mellitus aged between 8 and 21 may be accepted into the clinical trial. Necessary requirements are a diagnosis of Type 1 diabetes for at least three years, and to have reached adolescence or entered puberty."

Answered by AI

Is this research endeavor accepting volunteers who are over 25 years of age?

"Applicants of this research project must be between the ages 8 and 21."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
ACCESS: AI for pediatriC diabetiC Eye examS Study
2021. "ACCESS: AI for pediatriC diabetiC Eye examS Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05131451.
~49 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top